
"On May 11, 2026, Apollo-managed funds agreed to acquire Emerald Holding for $5.03 per share in cash, a 42.1% premium to the prior close, alongside the privately held Questex, in a transaction implying an enterprise value of approximately $1.5 billion. The combined entity becomes a leading North American B2B experiential events and media platform with approximately 160 events across diverse industries. Closing is expected in the second half of 2026, pending regulatory approvals."
"That deal landed in a remarkable week. Apollo and Blackstone are reportedly in talks to provide approximately $35 billion in financing to Broadcom for AI chip development, which would rank among the largest private credit transactions ever recorded. Apollo also agreed in April to acquire roughly a 13% minority stake in McKesson's Medical-Surgical Solutions for $1.25 billion, valuing the unit at about $13 billion, completed acquisition of a majority stake in France's Prosol Group on May 7, and earlier led a $225 million investment in Pickleball Inc. on May 1."
"First, the analyst spread skews positive. UBS carries a Buy rating with a $158 target, Barclays is Overweight at $131, J.P. Morgan is Overweight at $162, and Jefferies is Hold at $155. Second, analyst coverage momentum has shifted upward: BMO Capital lifted its price target to $140 from $108 on May 11, and Alpha Vantage's broader coverage shows four Strong Buy, 10 Buy, six Hold, and zero Sell ratings across 20 analysts. Third, positioning is heavy. Institutional ownership runs near 77%."
Apollo Global Management has a bullish outlook after a week of major deal activity. Analysts show a Moderate Buy consensus with an average price target of $146.71, and the upper end of the target range sits above the stock’s recent close despite a strong one-month rebound. Apollo-managed funds agreed to acquire Emerald Holding for $5.03 per share in cash, a 42.1% premium, alongside Questex, creating a leading North American B2B experiential events and media platform with about 160 events. Apollo is also involved in talks to provide about $35 billion in financing to Broadcom for AI chip development, agreed to buy a 13% minority stake in McKesson’s Medical-Surgical Solutions for $1.25 billion, completed a majority stake acquisition in Prosol Group, and invested in Pickleball Inc. Analyst ratings skew positive, price targets have risen, and institutional ownership is near 77%.
#private-credit #mergers-and-acquisitions #ai-chip-financing #b2b-events-media #institutional-investing
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]